+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Opportunities in Indian Stem Cell Market

  • ID: 3446388
  • Report
  • Region: India
  • 60 pages
  • RNCOS E-Services Private Limited
1 of 4
Indian Stem Cell Market to Surge Ahead By 2020

FEATURED COMPANIES

  • Cordlife India
  • ReeLabs Private Limited
  • Reliance Life Sciences
  • MORE
Realizing the potential of stem cells, the stem cell industry has been gaining ground in India over the past few years. Although, the market is still in a very nascent stage as compared to developed economies, like the US and Europe, it is expected to grow rapidly in the coming years. The stem cell market in India is mainly concentrated with companies offering stem cell banking facilities, and a very few players are involved in the commercialization of stem cell based products.

With intensive R&D efforts and increasing investments from both government and private organizations in stem cell research, stem cell therapy is expected to emerge as the new elixir for the treatment of various degenerative diseases. Moreover, the liberal regulations governing the stem cell market in India can be an important factor for attracting an increasing number of organizations to invest, create and commercialize promising technologies, thus driving further growth in the market.

According to the research report, “Opportunities in Indian Stem Cell Market”, India has the potential to become one of the fastest growing stem cell markets in the world, mainly owing to Stem Cell Banking segment, which is anticipated to grow at a CAGR of around 50% during 2014-2020. With a large number of clinical trials underway, the field of stem cell biology is likely to move towards translational research, and eventually to clinical practice in India.

The report has been authored to evaluate the Indian Stem Cell Market in terms of Stem Cell Banking and Stem Cell Research, so as to identify the market potential and future growth opportunities. It provides extensive research and analysis of the drivers responsible for the growth of this market, as well as the challenges being faced by the industry.

The report also provides an insight into the recent developments that have taken place in the industry. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities and potentials in the nascent Indian stem cell market.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cordlife India
  • ReeLabs Private Limited
  • Reliance Life Sciences
  • MORE
1. Analyst View

2. Research Methodology

3. Drivers
3.1 Rising Incidences of Chronic Diseases
3.2 Increasing Aging Population
3.3 Government Initiatives Accelerating Market Growth
3.4 Growing Medical Tourism

4. Challenges
4.1 Lack of Awareness
4.2 Lack of Sufficient Regulations
4.3 High Cost of Stem Cell Therapy and Banking

5. Stem Cell Products
5.1 Embryonic Stem Cells
5.2 Adult Stem Cells
5.3 Umbilical Cord Stem Cells
5.4 Dental Stem Cells

6. Stem Cell Applications
6.1 Regenerative Medicine
6.2 Drug Development

7. Stem Cell Industry Outlook
7.1 Stem Cell Banking
7.2 Stem Cell Research

8. Government Regulations

9. Recent Developments

10. Competitive Landscape
10.1 Reliance Life Sciences
10.2 LifeCell International Private Limited
10.3 Cryobanks International India Private Limited
10.4 Cryo-Save (India) Private Limited
10.5 Cordlife India
10.6 StemCyte India Therapeutics Private Limited
10.7 ReeLabs Private Limited
10.8 Stempeutics Research Private Limited
10.9 Regenerative Medical Services Private Limited
10.10 International Stemcell Services Limited

List of Figures:
Figure 3-1: India - Relative Burden of Chronic Conditions (2015)
Figure 3-2: India - Population Aged 60 and Above (Million), 2014 & 2050
Figure 3-3: India - Medical Tourism Market (Billion US$), 2014-2020
Figure 7-1: India - Stem Cell Banking Market (Million US$), 2014-2020

List of Tables:
Table 7-1: Stem Cell Clinical Trials Registered in Clinical Trials Registry - India (CTRI)
Table 10-1: Reliance Life Sciences - Stem Cell Products Offered
Table 10-2: Reliance Life Sciences - Programs Offered Under Cord Blood Repository Services
Table 10-3: LifeCell International Pvt. Ltd. - Umbilical Cord Stem Cell Banking Plans and Price
Table 10-4: Cryo-Save (India) Pvt. Ltd. - Umbilical Cord Blood Banking Price
Table 10-5: Cordlife India - Umbilical Cord Stem Cell Banking Plans and Price (21 Years Storage)
Table 10-6: Regenerative Medical Services Pvt. Ltd. - Stem Cell Therapy Products

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Cordlife India
  • ReeLabs Private Limited
  • Reliance Life Sciences
  • MORE
According to a new research report entitled, “Opportunities in Indian Stem Cell Market”, The Indian Stem Cell market is in a nascent stage of development and is anticipated to grow significantly in the years to come, as more stem cell researches translate into stem cell based therapies and products. The Indian stem cell market mainly comprises of the stem cell banking and stem cell research. The stem cell banking has emerged as the most promising segment of this market, with most of the players offering stem cell banking services for stem cells derived from the Umbilical cord. According to the RNCOS estimates, India has the potential to emerge as the leading source of umbilical cord stem cells, with stem cell banking segment growing at a healthy CAGR of 50.1% during the forecast period (2014-2020). Further growth in the sector can be propelled with increased awareness about the stem cell banking and its benefits, increased affordability, speedy regulatory approvals for stem cell based products and therapies and industry collaborations with global stem cell players.

Research Analysis and Highlights

The report, spanning across 60 pages, provides an overview of the Indian Stem Cell market with respect to Stem Cell Banking and Stem Cell Research. The report provides an in-depth analysis of the market segments along with the factors driving the industry growth, and challenges faced by the industry. In addition to this, the study includes an analysis of the regulations governing the stem cell sector and recent developments that have taken place in the market. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities and potentials in the nascent Indian stem cell market.

Some of the key highlights of the report include the following:

- Government initiatives accelerating market growth
- Challenges hindering the growth in the sector
- Recent developments in the stem cell market
Note: Product cover images may vary from those shown
5 of 4
- Cordlife India
- Cryo-Save (India) Private Limited
- Cryobanks International India Private Limited
- International Stemcell Services Limited
- LifeCell International Private Limited
- ReeLabs Private Limited
- Regenerative Medical Services Private Limited
- Reliance Life Sciences
- StemCyte India Therapeutics Private Limited
- Stempeutics Research Private Limited

Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/3446388
Adroll
adroll